Publication Date

1-1-2020

Journal

Frontiers in Endocrinology

DOI

10.3389/fendo.2020.00350

PMID

32547497

PMCID

PMC7272571

PubMedCentral® Posted Date

5-29-2020

PubMedCentral® Full Text Version

Post-print

Published Open-Access

yes

Keywords

Adult, Autoimmune Hypophysitis, Crohn Disease, Female, Humans, Immunosuppressive Agents, Infliximab, Treatment Outcome, Tumor Necrosis Factor-alpha, pituitary, granulomatous hypophysitis, inflammatory bowel disease, Crohn's disease, anti-TNF-alpha, infliximab, adalimumab, case report

Abstract

Associated Data

Share

COinS
 
 

To view the content in your browser, please download Adobe Reader or, alternately,
you may Download the file to your hard drive.

NOTE: The latest versions of Adobe Reader do not support viewing PDF files within Firefox on Mac OS and if you are using a modern (Intel) Mac, there is no official plugin for viewing PDF files within the browser window.